These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 29543818)

  • 1. Economic costs and health-related quality of life outcomes of hospitalised patients with high HIV prevalence: A prospective hospital cohort study in Malawi.
    Maheswaran H; Petrou S; Cohen D; MacPherson P; Kumwenda F; Lalloo DG; Corbett EL; Clarke A
    PLoS One; 2018; 13(3):e0192991. PubMed ID: 29543818
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Economic Costs and Health-Related Quality of Life Outcomes of HIV Treatment After Self- and Facility-Based HIV Testing in a Cluster Randomized Trial.
    Maheswaran H; Petrou S; MacPherson P; Kumwenda F; Lalloo DG; Corbett EL; Clarke A
    J Acquir Immune Defic Syndr; 2017 Jul; 75(3):280-289. PubMed ID: 28617733
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost and quality of life analysis of HIV self-testing and facility-based HIV testing and counselling in Blantyre, Malawi.
    Maheswaran H; Petrou S; MacPherson P; Choko AT; Kumwenda F; Lalloo DG; Clarke A; Corbett EL
    BMC Med; 2016 Feb; 14():34. PubMed ID: 26891969
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Individual and population level costs and health-related quality of life outcomes of third-generation cephalosporin resistant bloodstream infection in Blantyre, Malawi.
    Lester R; Mango J; Mallewa J; Jewell CP; Lalloo DA; Feasey NA; Maheswaran H
    PLOS Glob Public Health; 2023; 3(6):e0001589. PubMed ID: 37347746
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Cost of Illness of HIV Patients under Anteretroviral Therapy in Germany - Results of the 48-Week Interim Analysis of the Prospective Multicentre Observational Study 'CORSAR'].
    Kuhlmann A; Mittendorf T; Hower M; Heiken H; Gerschmann S; Klauke S; Lutz T; Bogner J; Degen O; van Lunzen J; Bachmann C; Stellbrink HJ; Schmidt W; Leistner I; Mahlich J; Ranneberg B; Stoll M
    Gesundheitswesen; 2015 Jun; 77(6):e133-42. PubMed ID: 25247761
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Infectious morbidity of breastfed, HIV-exposed uninfected infants under conditions of universal antiretroviral therapy in South Africa: a prospective cohort study.
    le Roux SM; Abrams EJ; Donald KA; Brittain K; Phillips TK; Zerbe A; le Roux DM; Kroon M; Myer L
    Lancet Child Adolesc Health; 2020 Mar; 4(3):220-231. PubMed ID: 31932246
    [TBL] [Abstract][Full Text] [Related]  

  • 7. What Is the Financial Impact of Orthopaedic Sequelae of Intravenous Drug Use on Urban Tertiary-care Centers?
    Dwivedi N; Breslin MA; McDermott A; Lin S; Vallier HA; Tornetta P
    Clin Orthop Relat Res; 2020 Oct; 478(10):2202-2212. PubMed ID: 32667752
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multi-country analysis of treatment costs for HIV/AIDS (MATCH): facility-level ART unit cost analysis in Ethiopia, Malawi, Rwanda, South Africa and Zambia.
    Tagar E; Sundaram M; Condliffe K; Matatiyo B; Chimbwandira F; Chilima B; Mwanamanga R; Moyo C; Chitah BM; Nyemazi JP; Assefa Y; Pillay Y; Mayer S; Shear L; Dain M; Hurley R; Kumar R; McCarthy T; Batra P; Gwinnell D; Diamond S; Over M
    PLoS One; 2014; 9(11):e108304. PubMed ID: 25389777
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sepsis carries a high mortality among hospitalised adults in Malawi in the era of antiretroviral therapy scale-up: a longitudinal cohort study.
    Waitt PI; Mukaka M; Goodson P; SimuKonda FD; Waitt CJ; Feasey N; Allain TJ; Downie P; Heyderman RS
    J Infect; 2015 Jan; 70(1):11-9. PubMed ID: 25043393
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of "test and treat" recommendations on eligibility for antiretroviral treatment: Cross sectional population survey data from three high HIV prevalence countries.
    Chihana ML; Huerga H; Van Cutsem G; Ellman T; Wanjala S; Masiku C; Szumilin E; Etard JF; Davies MA; Maman D
    PLoS One; 2018; 13(11):e0207656. PubMed ID: 30475865
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A stepped-wedge randomised trial on the impact of early ART initiation on HIV-patients' economic outcomes in Eswatini.
    Steinert JI; Khan S; Mlambo K; Walsh FJ; Mafara E; Lejeune C; Wong C; Hettema A; Ogbuoji O; Vollmer S; De Neve JW; Mazibuko S; Okello V; Bärnighausen T; Geldsetzer P
    Elife; 2020 Aug; 9():. PubMed ID: 32831169
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Physical activity levels among Malawian adults living with HIV and receiving anti-retroviral therapy.
    Chisati EM; Munthali F; Constantinou D; Lampiao F
    Malawi Med J; 2020 Mar; 32(1):8-12. PubMed ID: 32733653
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessing the costs and efficiency of HIV testing and treatment services in rural Malawi: implications for future "test and start" strategies.
    Vyas S; Songo J; Guinness L; Dube A; Geis S; Kalua T; Todd J; Renju J; Crampin A; Wringe A
    BMC Health Serv Res; 2020 Aug; 20(1):740. PubMed ID: 32787835
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Screening HIV-Infected Patients with Low CD4 Counts for Cryptococcal Antigenemia prior to Initiation of Antiretroviral Therapy: Cost Effectiveness of Alternative Screening Strategies in South Africa.
    Larson BA; Rockers PC; Bonawitz R; Sriruttan C; Glencross DK; Cassim N; Coetzee LM; Greene GS; Chiller TM; Vallabhaneni S; Long L; van Rensburg C; Govender NP
    PLoS One; 2016; 11(7):e0158986. PubMed ID: 27390864
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of genital infections in medical inpatients in Blantyre, Malawi.
    Maher D; Hoffman I
    J Infect; 1995 Jul; 31(1):77-8. PubMed ID: 8522842
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-effectiveness of urine-based tuberculosis screening in hospitalised patients with HIV in Africa: a microsimulation modelling study.
    Reddy KP; Gupta-Wright A; Fielding KL; Costantini S; Zheng A; Corbett EL; Yu L; van Oosterhout JJ; Resch SC; Wilson DP; Horsburgh CR; Wood R; Alufandika-Moyo M; Peters JA; Freedberg KA; Lawn SD; Walensky RP
    Lancet Glob Health; 2019 Feb; 7(2):e200-e208. PubMed ID: 30683239
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-effectiveness of early versus standard antiretroviral therapy in HIV-infected adults in Haiti.
    Koenig SP; Bang H; Severe P; Jean Juste MA; Ambroise A; Edwards A; Hippolyte J; Fitzgerald DW; McGreevy J; Riviere C; Marcelin S; Secours R; Johnson WD; Pape JW; Schackman BR
    PLoS Med; 2011 Sep; 8(9):e1001095. PubMed ID: 21949643
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The High Cost of HIV-Positive Inpatient Care at an Urban Hospital in Johannesburg, South Africa.
    Long LC; Fox MP; Sauls C; Evans D; Sanne I; Rosen SB
    PLoS One; 2016; 11(2):e0148546. PubMed ID: 26885977
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distribution of advanced HIV disease from three high HIV prevalence settings in Sub-Saharan Africa: a secondary analysis data from three population-based cross-sectional surveys in Eshowe (South Africa), Ndhiwa (Kenya) and Chiradzulu (Malawi).
    Chihana ML; Huerga H; Van Cutsem G; Ellman T; Goemaere E; Wanjala S; Masiku C; Szumilin E; Etard JF; Maman D; Davies MA
    Glob Health Action; 2019; 12(1):1679472. PubMed ID: 31679482
    [No Abstract]   [Full Text] [Related]  

  • 20. Differences in health-related quality of life between HIV-positive and HIV-negative people in Zambia and South Africa: a cross-sectional baseline survey of the HPTN 071 (PopART) trial.
    Thomas R; Burger R; Harper A; Kanema S; Mwenge L; Vanqa N; Bell-Mandla N; Smith PC; Floyd S; Bock P; Ayles H; Beyers N; Donnell D; Fidler S; Hayes R; Hauck K;
    Lancet Glob Health; 2017 Nov; 5(11):e1133-e1141. PubMed ID: 28964756
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.